Circulating tumor DNA analysis (ctDNA) for genomic testing in NSCLC patients with isolated CNS progression.

被引：0
|
作者：
Aldea, Mihaela
Mezquita, Laura
Hendriks, Lizza
Auclin, Edouard
Remon, Jordi
Planchard, David
Jovelet, Cecile
Carlos Benitez, Jose
Gazzah, Anas
Lavaud, Pernelle
Naltet, Charles
Lacroix, Ludovic
Morris, Clive D.
Green, Emma
Howarth, Karen
Nicotra, Claudio
Besse, Benjamin
机构：
[1] Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] MUMC, Maastricht, Netherlands
[3] Hop Europeen Georges Pompidou, Gastrointestinal Oncol Dept, Paris, France
[4] CIOCC Barcelona HM Delfos, Barcelona, Spain
[5] Gustave Roussy, Thorac Grp, Med Oncol Dept, Villejuif, France
[6] Gustave Roussy, Translat Reseach Lab, Villejuif, France
[7] Hosp Univ Mutua Terrassa, Barcelona, YT, Spain
[8] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[9] Gustave Roussy, Translat Res, Villejuif, France
[10] Inivata, Cambridge, Cheshire, England
[11] Inivata Ltd, Cambridge, England
[12] Paris Sud Univ, Orsay, France
[13] Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.2015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2015
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Feasibility of using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma
    Azzi, G.
    Tavallai, M.
    Aushev, V.
    Malashevich, A. E. Koyen
    Botta, G.
    Tejani, M.
    Hanna, D. L.
    Krinshpun, S.
    Malhotra, M.
    Olshan, P.
    Jurdi, A.
    Aleshin, A.
    Kasi, P. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1469 - S1469
  • [42] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced cancers of the GI tract and anus.
    Schrock, Alexa Betzig
    Young, Lauren
    Klempner, Samuel Jacob
    Bordoni, Rodolfo
    Ross, Jeffrey S.
    Stephens, Philip J.
    Devoe, Craig E.
    Braiteh, Fadi S.
    Ali, Siraj Mahamed
    Miller, Vincent A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma.
    Sandhu, Shahneen Kaur
    Wong, Stephan Q.
    Vergara, Ismael A.
    Raleigh, Jeanette
    Callahan, Jason
    Ftouni, Sarah
    Hatzimihalis, Athena
    Devbarna, Sinha
    Doig, Ken
    Colebatch, Andrew
    MirArnau, Gisela
    Cullinane, Carleen
    Gyorki, David E.
    Kee, Damien
    Brady, Benjamin M.
    Shackleton, Mark J.
    Papenfuss, Anthony
    Hicks, Rodney J.
    McArthur, Grant A.
    Dawson, Sarah-Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors
    Bar, J.
    Sharma, M. R.
    Kuboki, Y.
    Perets, R.
    Sommerhalder, D.
    Yamamoto, N.
    Powderly, J.
    Strickler, J. H.
    Li, M.
    Luo, A.
    Morrison-Thiele, G.
    Aristide, M. R. Neagu
    Vasilopoulos, A.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2023, 34 : S246 - S247
  • [45] Combined circulating tumour cell (CTC) and circulating tumor DNA (ctDNA) analysis of blood from patients with pancreatic cancer
    Brady, Ged
    Rothwell, Dominic
    Ayub, Mahmood
    Smith, Nigel
    Mohan, Sumitra
    Chudziak, Jakub
    Aung, Kyaw
    Hubner, Richard
    Miller, Crispin
    Backen, Alison
    Leong, Hui Sun
    Gulati, Sakshi
    Kim, Chang Sik
    Lamarca, Angela
    McNamara, Mairead
    Valle, Juan
    Dive, Caroline
    CANCER RESEARCH, 2016, 76
  • [46] Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of nonsmall cell lung cancer (NSCLC) - the MEDAL study
    Chen, Kezhong
    Wang, Chenyang
    Shen, Haifeng
    Li, Xi
    Jin, Yichen
    Wu, Shuailai
    Qiu, Fujun
    Lu, Qiang
    Peng, Di
    Fang, Shuai
    Li, Bing
    Lv, Juan
    Song, Jinlei
    Wang, Yang
    Chuai, Shannon
    Zhang, Zhihong
    CANCER RESEARCH, 2023, 83 (07)
  • [47] High circulating tumor DNA (ctDNA) concentration was associated with shorter progression free survival in patients with metastatic breast cancer
    Yi, Hanbaek
    Kim, Tae-Yong
    Song, Myung Geun
    Kim, Hwang-Phill
    Kim, Tae-You
    Kim, Jinyong
    Lee, Dae-Won
    Lee, Kyung-Hun
    Im, Seock-Ah
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA
    Gray, J. E.
    Peled, N.
    Markovets, A.
    Nogami, N.
    Lee, J-S.
    Cho, B. C.
    Chewaskulyong, B.
    Majem, M.
    Reungwetwattana, T.
    Vishwanathan, K.
    Todd, A.
    Rukazenkov, Y.
    Johnson, M.
    Barrett, C.
    Chmielecki, J.
    Hartmaier, R.
    Ramalingam, S. S.
    ANNALS OF ONCOLOGY, 2019, 30 : 921 - +
  • [49] Serial Circulating Tumor DNA (ctDNA) Analysis of Blood and Saliva Predicts Osimertinib Response and Resistance in EGFR-Mutant NSCLC
    Kim, C.
    Xi, L.
    Cultraro, C.
    Wei, F.
    Cheng, J.
    Shafiei, A.
    Pham, T.
    Roper, N.
    Akoth, E.
    Strom, C.
    Tu, M.
    Liao, W.
    Chia, D.
    Morris, C.
    Rajan, A.
    Bagheri, M.
    Jones, G.
    Wong, D.
    Raffeld, M.
    Guha, U.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S366 - S366
  • [50] Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA
    Reungwetwattana, T.
    Gray, J.
    Markovets, A.
    Nogami, N.
    Lee, J. S.
    Cho, B. C.
    Chewaskulyong, B.
    Majem, M.
    Peled, N.
    Vishwanathan, K.
    Todd, A.
    Rukazenkov, Y.
    Johnson, M.
    Barrett, C.
    Chmielecki, J.
    Hartmaier, R.
    Ramalingam, S.
    ANNALS OF ONCOLOGY, 2019, 30
12345